After a brief period of inactivity since the COVID-19 pandemic, the M&A market in the medical device industry is beginning to pick up again.
Spinal Tech
Orthopedic implant manufacturer Wishbone Medical appointed Jeff George to its board of directors on Aug. 12.
Following is a list of five key Zimmer Biomet developments that Becker's Spine Review has reported on since the World Health Organization declared COVID-19 a pandemic in March:
The COVID-19 pandemic has had a significant impact on first- and second-quarter revenues of medical device companies, with the spine and orthopedic industry taking a particularly seismic blow.
Here are five key notes on orthopedic and spine device companies from the past week:
Spinal implant developer SeaSpine has launched its Explorer TO system, an expandable cage for spinal fusions.
Here's how Medtronic, Stryker and Johnson & Johnson's shares have fluctuated over the last five days.
Spine device manufacturer Joimax received FDA approval Aug. 6 for Intracs, an electromagnetic navigation tracking and control system for spine surgery.
Stryker CEO Kevin Lobo said the pandemic accelerated innovation with virtual conferencing and connections during The Constellation Forum on Aug. 6, and he plans to lean into these trends as well as the company's social responsibility in the future.
Orthopedic implant manufacturer Wishbone Medical has strengthened its portfolio with the acquisition of two spine device companies — Back 2 Basics Direct and Orbbö Surgical.
